AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 161 filers reported holding AIMMUNE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $434,000 | +81.6% | 12,982 | +13.7% | 0.00% | +100.0% |
| Q3 2019 | $239,000 | -36.9% | 11,420 | -18.0% | 0.00% | -50.0% |
| Q3 2018 | $379,000 | +2.7% | 13,926 | +1.5% | 0.00% | 0.0% |
| Q2 2018 | $369,000 | -16.3% | 13,726 | -1.0% | 0.00% | 0.0% |
| Q1 2018 | $441,000 | -16.3% | 13,869 | -0.5% | 0.00% | -33.3% |
| Q4 2017 | $527,000 | – | 13,932 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|